Inactive Instrument

ALPA HEAL Stock

ALPA

US02073F1049

Alpha Healthcare Acquisition Corp. III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has not selected any specific business combination target and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company intend to focus on the healthcare industry. The Company has not conducted any operations and has not generated any revenues.

Employees

Sector

More about the company

15/11/23	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
15/08/23	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
17/07/23	Alpha Healthcare Acquisition Corp. III(NasdaqCM:ALPA) dropped from NASDAQ Composite Index	CI
15/07/23	Alpha Healthcare Acquisition Completes Combination With Carmell Therapeutics	MT
14/07/23	Carmell Therapeutics Corporation completed the acquisition of Alpha Healthcare Acquisition Corp. III from a group of shareholders in a reverse merger transaction.	CI
27/06/23	Alpha Healthcare Acquisition Executes Non-Binding Letter of Intent to Acquire Regenerative Medicine Company	MT
16/05/23	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
18/03/23	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Full Year Ended December 31, 2022	CI
18/03/23	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Full Year Ended December 31, 2022	CI
17/03/23	Alpha Healthcare Acquisition Corp. III Auditor Raises 'Going Concern' Doubt	CI
05/01/23	Alpha Healthcare Acquisition Corp. III to Merge With Carmell Therapeutics	MT
04/01/23	Alpha Healthcare Acquisition Corp. III executed a definitive business combination agreement to acquire Alpha Healthcare Acquisition Corp. III from a group of shareholders for approximately $150 million in a reverse merger transaction.	CI
04/01/23	Alpha Healthcare Acquisition Corp. III executed a definitive business combination agreement to acquire Carmell Therapeutics Corporation for approximately $150 million.	CI

21/03/24	Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary	AQ
18/03/24	Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field	AQ
26/02/24	Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024	AQ
16/11/23	Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors	AQ
16/11/23	ALPA HEAL : Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors - Form 8-K	PU

Date	Insider	Type	Main position	Quantity	% Market Cap.
14/07/23	AHAC Sponsor III LLC	Fiscal year	Company	3,786,026	90.0363%
26/07/21	AHAC Sponsor LLC	Other	Company	4,312,500	102.5565%
26/07/21	AHAC Sponsor III LLC	Other	Company	4,312,500	102.5565%

ALPA HEAL Stock

Stocks

ALPA

US02073F1049

Latest news : ALPA HEAL

Press Releases: ALPA HEAL

Quotes and Performance

Latest insider transactions

Company Profile